The 2, 3-bis (4-hydeoxyphenyl)-propionitrile (DPN) activates mTOR pathway in EAE mice, while liquiritigenin inhibits mTOR activation in glioma cells [8, 24]. This evidence concerns the gene MTOR and central nervous system cancer.